3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.65
-0.35 (-1.21%)
May 29, 2026, 1:35 PM CST
Market Cap2.27B -42.0%
Revenue (ttm)206.74M -22.2%
Net Income66.53M -27.5%
EPS0.84 -35.4%
Shares Out 76.98M
PE Ratio35.06
Forward PEn/a
Dividend0.10 (0.34%)
Ex-Dividend Daten/a
Volume97,884
Open29.05
Previous Close29.00
Day's Range28.50 - 29.50
52-Week Range27.90 - 63.00
Beta0.30
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About 3D Global Biotech

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

In 2025, 3D Global Biotech's revenue was 206.74 million, a decrease of -22.19% compared to the previous year's 265.69 million. Earnings were 66.53 million, a decrease of -27.45%.

Financial Statements